This inventor holds 1 USPTO granted patent. Top assignee: Glycomimetics, Inc.. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: The Innovations of Jonas K Egger
Introduction
Jonas K Egger is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of biomedical research, particularly in the development of compounds that inhibit E-selectin binding. His work has the potential to impact various therapeutic areas.
Latest Patents
Jonas K Egger holds a patent for E-selectin antagonists. This patent includes compounds, compositions, and methods designed to inhibit in vitro and in vivo processes mediated by E-selectin binding. Specifically, the patent describes particular glycomimetic compounds that function as E-selectin antagonists.
Career Highlights
Jonas K Egger is associated with Glycomimetics, Inc., where he continues to advance his research and innovations. His work focuses on the development of novel therapeutic agents that can address critical medical needs.
Collaborations
He collaborates with esteemed colleagues such as Beat Ernst and Céline E Weckerle, contributing to a dynamic research environment that fosters innovation.
Conclusion
Jonas K Egger's contributions to the field of biomedical research, particularly through his patent on E-selectin antagonists, highlight his role as a significant inventor in the industry. His ongoing work at Glycomimetics, Inc. continues to pave the way for future advancements in medical therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile